PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 22, 2015Clinical Trials347 citationsOpen Access

Fallacies of last observation carried forward analyses

View Full Paper
JLJohn M. Lachin

Key Points

Key points are not available for this paper at this time.

Abstract

All analyses using last observation carried forward are of questionable veracity, if not being outright specious (definition: appearing to be true but actually false). It is hoped that future studies will make a more vigorous attempt to minimize the amount of missing data and that more valid statistical analyses will be employed in cases where missing data occur. Last observation carried forward should not be employed in any analyses.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

John M. Lachin (2015) studied this question.

synapsesocial.com/papers/69dae36600ab073a278394ffhttps://doi.org/10.1177/1740774515602688
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It2012 · 184 citations
  2. 2U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group1995 · 794 citations
  3. 3Statistical Analysis with Missing Data2002 · 8,472 citations
  4. 4Estimation in Mixtures of Two Normal Distributions1967 · 190 citations
  5. 5U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease1995 · 1,927 citations